3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
14
Prostatic Neoplasms
9
Leukemia, Myeloid, Acute
9
Endometrial Neoplasms
8
Breast Neoplasms
7
Oropharyngeal Neoplasms
5
Neoplasm Metastasis
5
Melanoma
5
Lung Neoplasms
5
Colonic Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Neoplasms
4
Multiple Myeloma
4
Lymphoma, Mantle-Cell
4
Lymphoma, Large B-Cell, Diffuse
4
Leukemia, Myelomonocytic, Acute
4
Leukemia, Monocytic, Acute
4
Leukemia, Megakaryoblastic, Acute
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Leukemia, Erythroblastic, Acute
4
Congenital Abnormalities
4
Colorectal Neoplasms
4
Stomach Neoplasms
3
Rectal Neoplasms
3
Neuroblastoma
3
Mouth Neoplasms
3
Lymphoma, Follicular
3
Leukemia
3
Esophageal Neoplasms
3
Brain Neoplasms
3
Interventions
Cisplatin
76
Radiotherapy
44
pembrolizumab
39
Cetuximab
38
Paclitaxel
34
Carboplatin
33
Docetaxel
30
Fluorouracil
25
Radiotherapy, Intensity-Modulated
22
Nivolumab
18
Drug Therapy
14
Radiation
12
Erlotinib Hydrochloride
9
cemiplimab
8
Magnetic Resonance Spectroscopy
8
130-nm albumin-bound paclitaxel
8
durvalumab
7
atezolizumab
7
Cyclophosphamide
7
Afatinib
7
Surgical Procedures, Operative
6
Panitumumab
6
Leucovorin
6
Chemoradiotherapy
6
fludarabine
5
aldesleukin
5
Radiosurgery
5
Oxaliplatin
5
Methotrexate
5
Gemcitabine
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Carcinoma, Squamous Cell
×
Observation
×
Clear all
NCT02503111
2022-06-13
HPV-SAVE
University Health Network, Toronto
Phase NA
Terminated
71 enrolled